Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Acquisition of class C β-lactamase PAC-1 by ST664 strains of Pseudomonas aeruginosa.

Bour M, Fournier D, Jové T, Pouzol A, Miltgen G, Janvier F, Jeannot K, Plésiat P.

Antimicrob Agents Chemother. 2019 Sep 16. pii: AAC.01375-19. doi: 10.1128/AAC.01375-19. [Epub ahead of print]

PMID:
31527025
2.

Editorial: Horizontal Gene Transfer Mediated Bacterial Antibiotic Resistance.

Sun D, Jeannot K, Xiao Y, Knapp CW.

Front Microbiol. 2019 Aug 27;10:1933. doi: 10.3389/fmicb.2019.01933. eCollection 2019. No abstract available.

3.

Production of Norspermidine Contributes to Aminoglycoside Resistance in pmrAB Mutants of Pseudomonas aeruginosa.

Bolard A, Schniederjans M, Haüssler S, Triponney P, Valot B, Plésiat P, Jeannot K.

Antimicrob Agents Chemother. 2019 Sep 23;63(10). pii: e01044-19. doi: 10.1128/AAC.01044-19. Print 2019 Oct.

PMID:
31383668
4.

Identification of Diverse Integron and Plasmid Structures Carrying a Novel Carbapenemase Among Pseudomonas Species.

Liapis E, Bour M, Triponney P, Jové T, Zahar JR, Valot B, Jeannot K, Plésiat P.

Front Microbiol. 2019 Mar 4;10:404. doi: 10.3389/fmicb.2019.00404. eCollection 2019.

5.

Azetidine-Containing Alkaloids Produced by a Quorum-Sensing Regulated Nonribosomal Peptide Synthetase Pathway in Pseudomonas aeruginosa.

Hong Z, Bolard A, Giraud C, Prévost S, Genta-Jouve G, Deregnaucourt C, Häussler S, Jeannot K, Li Y.

Angew Chem Int Ed Engl. 2019 Mar 4;58(10):3178-3182. doi: 10.1002/anie.201809981. Epub 2019 Jan 14.

PMID:
30548135
6.

A novel IncQ plasmid carrying gene blaCTX-M-3 in Pseudomonas aeruginosa.

Jeannot K, Danassie M, Triponney P, Bour M, Gueudet T, Beyrouthy R, Bonnet R, Plésiat P.

J Antimicrob Chemother. 2019 Mar 1;74(3):823-825. doi: 10.1093/jac/dky454. No abstract available.

PMID:
30403778
7.

Mutations in Gene fusA1 as a Novel Mechanism of Aminoglycoside Resistance in Clinical Strains of Pseudomonas aeruginosa.

Bolard A, Plésiat P, Jeannot K.

Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e01835-17. doi: 10.1128/AAC.01835-17. Print 2018 Feb.

8.

Resistance of Animal Strains of Pseudomonas aeruginosa to Carbapenems.

Haenni M, Bour M, Châtre P, Madec JY, Plésiat P, Jeannot K.

Front Microbiol. 2017 Sep 29;8:1847. doi: 10.3389/fmicb.2017.01847. eCollection 2017.

9.

Toxic Electrophiles Induce Expression of the Multidrug Efflux Pump MexEF-OprN in Pseudomonas aeruginosa through a Novel Transcriptional Regulator, CmrA.

Juarez P, Jeannot K, Plésiat P, Llanes C.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00585-17. doi: 10.1128/AAC.00585-17. Print 2017 Aug.

10.

Resistance to polymyxins in Gram-negative organisms.

Jeannot K, Bolard A, Plésiat P.

Int J Antimicrob Agents. 2017 May;49(5):526-535. doi: 10.1016/j.ijantimicag.2016.11.029. Epub 2017 Feb 3. Review.

PMID:
28163137
11.

A case of multiple contamination with methylase ArmA-producing pathogens.

Janvier F, Otto MP, Jové T, Mille A, Contargyris C, Meaudre E, Brisou P, Plésiat P, Jeannot K.

J Antimicrob Chemother. 2017 Feb;72(2):618-620. doi: 10.1093/jac/dkw418. Epub 2016 Sep 28. No abstract available.

PMID:
28073962
12.

First Detection of GES-5 Carbapenemase-Producing Acinetobacter baumannii Isolate.

Al-Agamy MH, Jeannot K, El-Mahdy TS, Shibl AM, Kattan W, Plésiat P, Courvalin P.

Microb Drug Resist. 2017 Jul;23(5):556-562. doi: 10.1089/mdr.2016.0152. Epub 2016 Nov 17.

PMID:
27854148
13.

Diversity of Molecular Mechanisms Conferring Carbapenem Resistance to Pseudomonas aeruginosa Isolates from Saudi Arabia.

Al-Agamy MH, Jeannot K, El-Mahdy TS, Samaha HA, Shibl AM, Plésiat P, Courvalin P.

Can J Infect Dis Med Microbiol. 2016;2016:4379686. doi: 10.1155/2016/4379686. Epub 2016 Aug 11.

14.

Phenotype and toxicity of the recently discovered exlA-positive Pseudomonas aeruginosa strains collected worldwide.

Reboud E, Elsen S, Bouillot S, Golovkine G, Basso P, Jeannot K, Attrée I, Huber P.

Environ Microbiol. 2016 Oct;18(10):3425-3439. doi: 10.1111/1462-2920.13262. Epub 2016 Apr 21.

PMID:
26914644
15.

Amino Acid Substitutions Account for Most MexS Alterations in Clinical nfxC Mutants of Pseudomonas aeruginosa.

Richardot C, Juarez P, Jeannot K, Patry I, Plésiat P, Llanes C.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2302-10. doi: 10.1128/AAC.02622-15. Print 2016 Apr.

16.

Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins.

Berrazeg M, Jeannot K, Ntsogo Enguéné VY, Broutin I, Loeffert S, Fournier D, Plésiat P.

Antimicrob Agents Chemother. 2015 Oct;59(10):6248-55. doi: 10.1128/AAC.00825-15. Epub 2015 Jul 27.

17.

Genetic and biochemical characterization of OXA-405, an OXA-48-type extended-spectrum β-lactamase without significant carbapenemase activity.

Dortet L, Oueslati S, Jeannot K, Tandé D, Naas T, Nordmann P.

Antimicrob Agents Chemother. 2015 Jul;59(7):3823-8. doi: 10.1128/AAC.05058-14. Epub 2015 Apr 13.

18.

Type III secretion system and virulence markers highlight similarities and differences between human- and plant-associated pseudomonads related to Pseudomonas fluorescens and P. putida.

Mazurier S, Merieau A, Bergeau D, Decoin V, Sperandio D, Crépin A, Barbey C, Jeannot K, Vicré-Gibouin M, Plésiat P, Lemanceau P, Latour X.

Appl Environ Microbiol. 2015 Apr;81(7):2579-90. doi: 10.1128/AEM.04160-14. Epub 2015 Jan 30.

19.

Molecular epidemiology of carbapenem non-susceptible Acinetobacter baumannii in France.

Jeannot K, Diancourt L, Vaux S, Thouverez M, Ribeiro A, Coignard B, Courvalin P, Brisse S.

PLoS One. 2014 Dec 17;9(12):e115452. doi: 10.1371/journal.pone.0115452. eCollection 2014.

20.

Pseudomonas aeruginosa Genome Evolution in Patients and under the Hospital Environment.

Lucchetti-Miganeh C, Redelberger D, Chambonnier G, Rechenmann F, Elsen S, Bordi C, Jeannot K, Attrée I, Plésiat P, de Bentzmann S.

Pathogens. 2014 Apr 10;3(2):309-40. doi: 10.3390/pathogens3020309.

21.

New amphiphilic neamine derivatives active against resistant Pseudomonas aeruginosa and their interactions with lipopolysaccharides.

Sautrey G, Zimmermann L, Deleu M, Delbar A, Souza Machado L, Jeannot K, Van Bambeke F, Buyck JM, Decout JL, Mingeot-Leclercq MP.

Antimicrob Agents Chemother. 2014 Aug;58(8):4420-30. doi: 10.1128/AAC.02536-13. Epub 2014 May 27.

22.

Drug susceptibility testing by dilution methods.

Jeannot K, Plésiat P.

Methods Mol Biol. 2014;1149:49-58. doi: 10.1007/978-1-4939-0473-0_6.

PMID:
24818896
23.

Antibiotic resistance determinants in a Pseudomonas putida strain isolated from a hospital.

Molina L, Udaondo Z, Duque E, Fernández M, Molina-Santiago C, Roca A, Porcel M, de la Torre J, Segura A, Plesiat P, Jeannot K, Ramos JL.

PLoS One. 2014 Jan 17;9(1):e81604. doi: 10.1371/journal.pone.0081604. eCollection 2014.

24.

Multiple mutations lead to MexXY-OprM-dependent aminoglycoside resistance in clinical strains of Pseudomonas aeruginosa.

Guénard S, Muller C, Monlezun L, Benas P, Broutin I, Jeannot K, Plésiat P.

Antimicrob Agents Chemother. 2014;58(1):221-8. doi: 10.1128/AAC.01252-13. Epub 2013 Oct 21. Erratum in: Antimicrob Agents Chemother. 2014 Mar;58(3):1833.

25.

A convenient method to screen for carbapenemase-producing Pseudomonas aeruginosa.

Fournier D, Garnier P, Jeannot K, Mille A, Gomez AS, Plésiat P.

J Clin Microbiol. 2013 Nov;51(11):3846-8. doi: 10.1128/JCM.01299-13. Epub 2013 Aug 21.

26.

Outbreak of metallo-β-lactamase VIM-2-positive strains of Pseudomonas aeruginosa in the Ivory Coast.

Jeannot K, Guessennd N, Fournier D, Müller E, Gbonon V, Plésiat P.

J Antimicrob Chemother. 2013 Dec;68(12):2952-4. doi: 10.1093/jac/dkt296. Epub 2013 Jul 25. No abstract available.

PMID:
23887865
27.

Molecular characterization of blaNDM-1 in a sequence type 235 Pseudomonas aeruginosa isolate from France.

Janvier F, Jeannot K, Tessé S, Robert-Nicoud M, Delacour H, Rapp C, Mérens A.

Antimicrob Agents Chemother. 2013 Jul;57(7):3408-11. doi: 10.1128/AAC.02334-12. Epub 2013 Apr 22.

28.

Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa.

Fournier D, Richardot C, Müller E, Robert-Nicoud M, Llanes C, Plésiat P, Jeannot K.

J Antimicrob Chemother. 2013 Aug;68(8):1772-80. doi: 10.1093/jac/dkt098. Epub 2013 Apr 14.

PMID:
23587654
29.

Clonal dissemination of Pseudomonas aeruginosa isolates producing extended-spectrum β-lactamase SHV-2a.

Jeannot K, Fournier D, Müller E, Cholley P, Plésiat P.

J Clin Microbiol. 2013 Feb;51(2):673-5. doi: 10.1128/JCM.02313-12. Epub 2012 Dec 12.

30.

Unique biofilm signature, drug susceptibility and decreased virulence in Drosophila through the Pseudomonas aeruginosa two-component system PprAB.

de Bentzmann S, Giraud C, Bernard CS, Calderon V, Ewald F, Plésiat P, Nguyen C, Grunwald D, Attree I, Jeannot K, Fauvarque MO, Bordi C.

PLoS Pathog. 2012;8(11):e1003052. doi: 10.1371/journal.ppat.1003052. Epub 2012 Nov 29. Erratum in: PLoS Pathog. 2012 Dec;8(12). doi: 10.1371/annotation/5c169544-7d19-40db-9a58-28b2fdf2c82c.

31.

Recurrent pyelonephritis due to NDM-1 metallo-beta-lactamase producing Pseudomonas aeruginosa in a patient returning from Serbia, France, 2012.

Flateau C, Janvier F, Delacour H, Males S, Ficko C, Andriamanantena D, Jeannot K, Merens A, Rapp C.

Euro Surveill. 2012 Nov 8;17(45). pii: 20311.

32.

Spread of the bla(IMP-13) gene in French Pseudomonas aeruginosa through sequence types ST621, ST308 and ST111.

Fournier D, Jeannot K, Robert-Nicoud M, Muller E, Cholley P, van der Mee-Marquet N, Plésiat P.

Int J Antimicrob Agents. 2012 Dec;40(6):571-3. doi: 10.1016/j.ijantimicag.2012.08.006. Epub 2012 Oct 23. No abstract available.

PMID:
23089049
33.

IMP-29, a novel IMP-type metallo-β-lactamase in Pseudomonas aeruginosa.

Jeannot K, Poirel L, Robert-Nicoud M, Cholley P, Nordmann P, Plésiat P.

Antimicrob Agents Chemother. 2012 Apr;56(4):2187-90. doi: 10.1128/AAC.05838-11. Epub 2012 Jan 30.

34.

A two-component regulatory system interconnects resistance to polymyxins, aminoglycosides, fluoroquinolones, and β-lactams in Pseudomonas aeruginosa.

Muller C, Plésiat P, Jeannot K.

Antimicrob Agents Chemother. 2011 Mar;55(3):1211-21. doi: 10.1128/AAC.01252-10. Epub 2010 Dec 13.

35.

Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.

Jeannot K, Elsen S, Köhler T, Attree I, van Delden C, Plésiat P.

Antimicrob Agents Chemother. 2008 Jul;52(7):2455-62. doi: 10.1128/AAC.01107-07. Epub 2008 May 12.

36.

Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.

Hocquet D, Berthelot P, Roussel-Delvallez M, Favre R, Jeannot K, Bajolet O, Marty N, Grattard F, Mariani-Kurkdjian P, Bingen E, Husson MO, Couetdic G, Plésiat P.

Antimicrob Agents Chemother. 2007 Oct;51(10):3531-6. Epub 2007 Aug 6.

37.

Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.

El'Garch F, Jeannot K, Hocquet D, Llanes-Barakat C, Plésiat P.

Antimicrob Agents Chemother. 2007 Mar;51(3):1016-21. Epub 2006 Dec 28.

38.

[Low-level resistance to fluoroquinolones conferred by efflux overproduction in Pseudomonas aeruginosa: clinical significance and routine detection].

Hocquet D, Patry I, Dupont P, Bize M, Jeannot K, Chavanet P, Plésiat P.

Pathol Biol (Paris). 2005 Oct-Nov;53(8-9):495-9. Epub 2005 Oct 3. French.

PMID:
16203109
39.

Induction of the MexXY efflux pump in Pseudomonas aeruginosa is dependent on drug-ribosome interaction.

Jeannot K, Sobel ML, El Garch F, Poole K, Plésiat P.

J Bacteriol. 2005 Aug;187(15):5341-6.

40.

Bacteriostatic and bactericidal activities of eight fluoroquinolones against MexAB-OprM-overproducing clinical strains of Pseudomonas aeruginosa.

Dupont P, Hocquet D, Jeannot K, Chavanet P, Plésiat P.

J Antimicrob Chemother. 2005 Apr;55(4):518-22. Epub 2005 Feb 18.

PMID:
15722391

Supplemental Content

Loading ...
Support Center